Anakinra provisionally recommended for Still’s disease

In its draft guidance, NICE recommends the treatment in specific cases as an option for treating Still’s disease with moderate to high disease activity, or continued disease activity after NSAIDs or glucocorticoids.

Please sign in or register for FREE

No comments yet.